Indolyl derivatives

摘要

The present invention provides compounds of formula I as well as pharmaceutically acceptable salts and esters thereof, wherein R¹ to R⁴, A and n have the significance given in the specification. The compounds or their salts may be administered to a patient for treating non-insulin dependent diabetes mellitus.